BrainPharm: Pathological mechanism

	Name
1	Glutamatergic synaptic depression by synthetic amyloid beta-peptide in the medial septum.

This database was supported by the Human Brain Project (NIDCD, NIMH, NIA, NICD, NINDS) and MURI (Multidisciplinary University Research Initiative). It is now supported by RO1 DC 009977 from the National Institute for Deafness and other Communication Disorders.

Questions, comments, problems? Email the Brain Pharm Administrator
This site is Copyright @1998-2023 Shepherd Lab, Yale University

Pathological mechanism (s) having Calcicludine as Pharmacological Agent